.Possessing presently scooped up the U.S. rights to Capricor Therapeutics' late-stage Duchenne muscu...
.After pushing back the selection meeting for Applied Therapeutics' metabolic problem medicine govor...
.Novo Nordisk is actually continuing its own press right into genetic medications, accepting to pay ...
.Innovent Biologics has actually helped make the instance that its gate inhibitor-cytokine fusion pr...
.A period 3 trial of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate ...
.5 months after Rakovina Therapies rotated towards artificial intelligence, the cancer-focused biote...
.Ascendis Pharma has emerged as a possible danger to BioMarin's Voxzogo, reporting phase 3 growth co...
.Though Alkeus Pharmaceuticals' oral eye disease asset failed to substantially minimize geographic d...
.Along with a trio of biotechs attacking the Nasdaq on Friday, it was actually quick and easy to ove...
.Immune checkpoint preventions are actually the superheroes of cancer cells treatment. Medications l...
.Welcome to today's Chutes & Ladders, our summary of considerable leadership hirings, firings and...
.Regeneron is actually back with long-lasting follow-up for its own LAG-3 inhibitor as well as PD-1 ...
.AstraZeneca has actually discussed an early check out the performance of its internal antibody-drug...
.After introducing a phase 3 launch based upon beneficial midstage end results, iTeos as well as GSK...
.The FDA needs to be a lot more available as well as joint to discharge a rise in approvals of uncom...
.It's an unusually hectic Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara Thera...
.Atea Pharmaceuticals' antiviral has stopped working another COVID-19 test, but the biotech still ho...
.Neurocrine Biosciences' mental illness system pivot has actually stopped working. The biotech was u...
.Sanofi has actually brought in a late entry to the radioligand party, paying one hundred million eu...
.After F2G's 1st effort to get a brand-new lesson of antifungal to market was thwarted by the FDA, t...